Skip to the page

Data / Form D filings / Tavros Therapeutics, Inc.

Tavros Therapeutics, Inc.: Form D filing

Tavros Therapeutics, Inc., a technology company in Durham, NC, filed a Form D with the SEC in 2020. The latest, on March 17, 2020, reports $999,996 sold of a $3 million offering to 1 investor.

Find out what Tavros Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
701 WEST MAIN ST., SUITE 200, Durham, NC, 27701
Phone
(919) 602-2631
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1806643

The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Other Technology: 8,166 rows, $161.66, or the new rows each week for $19.25 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 17, 2020New notice$3,000,000$999,996$2,000,0041Mar 2, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kris WoodDirector
Eoin McDonnellExecutive Officer, Director

Other technology companies in North Carolina that filed recently

Every Form D from the week of Mar 16, 2020 · All recent filings in North Carolina · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Tavros Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.